Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.86
-0.3088-0.90%
Post-market: 33.860.00000.00%16:10 EDT
Volume:5K
Turnover:153.07K
Market Cap:13.54M
PE:- -
High:34.24
Open:34.24
Low:33.86
Close:34.17
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:7.80
T/O Rate:1.13%
Dividend:0.08
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Hengrui Pharma Subsidiary Gains Clinical Trial Approval for Weight Management Drug Candidate

Stock News
·
Sep 07

Chongqing Zhifei Biological Receives Clinical Trial Approval for Recombinant Rotavirus Subunit Vaccine

Stock News
·
Sep 07

Hualan Vaccine's Novel Influenza mRNA Vaccine Clears Clinical Trial Hurdle, No Domestic Competitors Yet

Stock News
·
Sep 07

Gan&Lee Pharmaceuticals Begins Phase I Dosing in GZC8072 Obesity and Diabetes Study

Stock News
·
Sep 07

Vitura hit by BUPA telehealth shift but reiterates FY2027 growth outlook

TIPRANKS
·
Sep 07

Gen İlaç boosts control of Neo Auvra with majority stake in digital health firm

TIPRANKS
·
Sep 06

Nvidia, TSMC, Salesforce, CrowdStrike, J&J Insider Shake‑Up

TIPRANKS
·
Sep 05

Top Johnson & Johnson Executive Makes Major Stock Move

TIPRANKS
·
Sep 05

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

TIPRANKS
·
Sep 05

Estee Lauder Cos. Cl a Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 05

Merck & Co. Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

This Biotech Wins a Big FDA Approval. Why Wall Street is Shrugging.

Dow Jones
·
Sep 05

Merck Price Target Raised to $170.00/Share from $150.00 by Wells Fargo

Dow Jones
·
Sep 04

Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping

Reuters
·
Sep 04

J&J EVP, Worldwide Chair MedTech Timothy Schmid Disposes of 33,597 Common Shares Worth $9.23 Million

Reuters
·
Sep 04

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Dow Jones
·
Sep 04

Patient Dies in CAR-T Trial, Director Tells Reporter to "Get Lost," IPO Filed Just 15 Days Earlier — Family Demands Answers

Deep News
·
Sep 04

Wells Fargo Adjusts Price Target on Merck & Co. to $170 From $150, Keeps Overweight Rating

MT Newswires Live
·
Sep 04

Correction: Eisai, Biogen Secure China's Nod for Self-Injection Version of Leqembi

MT Newswires Live
·
Sep 04

Stoke Therapeutics, Biogen present long-term data on Zorevunersen

TIPRANKS
·
Sep 04